Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Unique features of the Trypanosoma cruzi U2AF35 splicing factor.
Vázquez M, Atorrasagasti C, Bercovich N, Volcovich R, Levin MJ. Vázquez M, et al. Among authors: atorrasagasti c. Mol Biochem Parasitol. 2003 Apr 25;128(1):77-81. doi: 10.1016/s0166-6851(03)00007-0. Mol Biochem Parasitol. 2003. PMID: 12706799 No abstract available.
Trypanosoma cruzi: analysis of the complete PUF RNA-binding protein family.
Caro F, Bercovich N, Atorrasagasti C, Levin MJ, Vázquez MP. Caro F, et al. Among authors: atorrasagasti c. Exp Parasitol. 2006 Jun;113(2):112-24. doi: 10.1016/j.exppara.2005.12.015. Epub 2006 Feb 7. Exp Parasitol. 2006. PMID: 16460732
Protein interactions within the TcZFP zinc finger family members of Trypanosoma cruzi: implications for their functions.
Caro F, Bercovich N, Atorrasagasti C, Levin MJ, Vázquez MP. Caro F, et al. Among authors: atorrasagasti c. Biochem Biophys Res Commun. 2005 Aug 5;333(3):1017-25. doi: 10.1016/j.bbrc.2005.06.007. Biochem Biophys Res Commun. 2005. PMID: 15964555
Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12.
Malvicini M, Ingolotti M, Piccioni F, Garcia M, Bayo J, Atorrasagasti C, Alaniz L, Aquino JB, Espinoza JA, Gidekel M, Scharovsky OG, Matar P, Mazzolini G. Malvicini M, et al. Among authors: atorrasagasti c. Mol Oncol. 2011 Jun;5(3):242-55. doi: 10.1016/j.molonc.2011.03.007. Epub 2011 Apr 5. Mol Oncol. 2011. PMID: 21515097 Free PMC article.
We previously demonstrated that sub-therapeutic doses of an adenovirus expressing IL-12 genes (AdIL-12) mediated a potent antitumour effect against subcutaneous (s.c.) colorectal carcinomas (CRC) in mice pre-treated with low doses of cyclophosphamide (Cy). ...In s.c
We previously demonstrated that sub-therapeutic doses of an adenovirus expressing IL-12 genes (AdIL-12) mediated a potent antitumour effect …
Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice.
Atorrasagasti C, Peixoto E, Aquino JB, Kippes N, Malvicini M, Alaniz L, Garcia M, Piccioni F, Fiore EJ, Bayo J, Bataller R, Guruceaga E, Corrales F, Podhajcer O, Mazzolini G. Atorrasagasti C, et al. PLoS One. 2013;8(2):e54962. doi: 10.1371/journal.pone.0054962. Epub 2013 Feb 11. PLoS One. 2013. PMID: 23408952 Free PMC article.
SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage.
Peixoto E, Atorrasagasti C, Aquino JB, Militello R, Bayo J, Fiore E, Piccioni F, Salvatierra E, Alaniz L, García MG, Bataller R, Corrales F, Gidekel M, Podhajcer O, Colombo MI, Mazzolini G. Peixoto E, et al. Among authors: atorrasagasti c. Gene Ther. 2015 Jan;22(1):9-19. doi: 10.1038/gt.2014.102. Epub 2014 Nov 20. Gene Ther. 2015. PMID: 25410742 Free PMC article.
SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF.
Atorrasagasti C, Aquino JB, Hofman L, Alaniz L, Malvicini M, Garcia M, Benedetti L, Friedman SL, Podhajcer O, Mazzolini G. Atorrasagasti C, et al. Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G739-48. doi: 10.1152/ajpgi.00316.2010. Epub 2011 Feb 10. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21311029 Free PMC article.
Immunotherapy and immunoescape in colorectal cancer.
Mazzolini G, Murillo O, Atorrasagasti C, Dubrot J, Tirapu I, Rizzo M, Arina A, Alfaro C, Azpilicueta A, Berasain C, Perez-Gracia JL, Gonzalez A, Melero I. Mazzolini G, et al. Among authors: atorrasagasti c. World J Gastroenterol. 2007 Nov 28;13(44):5822-31. doi: 10.3748/wjg.v13.i44.5822. World J Gastroenterol. 2007. PMID: 17990348 Free PMC article. Review.
A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
Bayo J, Fiore EJ, Dominguez LM, Real A, Malvicini M, Rizzo M, Atorrasagasti C, García MG, Argemi J, Martinez ED, Mazzolini GD. Bayo J, et al. Among authors: atorrasagasti c. J Hepatol. 2019 Jul;71(1):78-90. doi: 10.1016/j.jhep.2019.03.007. Epub 2019 Mar 15. J Hepatol. 2019. PMID: 30880225
Immunotherapy for liver tumors: present status and future prospects.
Matar P, Alaniz L, Rozados V, Aquino JB, Malvicini M, Atorrasagasti C, Gidekel M, Silva M, Scharovsky OG, Mazzolini G. Matar P, et al. Among authors: atorrasagasti c. J Biomed Sci. 2009 Mar 6;16(1):30. doi: 10.1186/1423-0127-16-30. J Biomed Sci. 2009. PMID: 19272130 Free PMC article. Review.
27 results
Jump to page
Feedback